Meiji Holdings Co., Ltd.

2026/08/03 Updated
Market Cap: $6.5B (¥1.0T)
Stock Price: $23.98 (¥3,789)
Exchange Rate: 1 USD = ¥157.98

Stock Price Chart

2026/08/03 Updated
29.24
PER (Price Earnings Ratio)
vs Industry Avg: +19.7
1.33
PBR (Price to Book Ratio)
vs Industry Avg: +0.0
2.90%
Dividend Yield
vs Industry Avg: -0.05%

Price Trend

2026/08/03 Updated
Short-term
5-Day MA
-2.02%
Near-term
25-Day MA
-0.52%
Mid-term
75-Day MA
+1.24%
Long-term
200-Day MA
+5.93%

Price & Trading Details

2026/08/03 Updated

PRICE

Previous Close ¥3,948
Open ¥3,831
High ¥3,917
Low ¥3,768
Close ¥3,789

TRADING

Volume 1,553,100
Average Volume 1,031,103
Turnover ¥59億
Min. Purchase ¥378,900

Analyst Recommendations 9 analysts

Updated 2026/08/01
Strong Buy
2
2
Buy
1
1
Hold
6
6
Sell
0
Strong Sell
0
Target Price (Mean)
¥4,330
Buy
¥5,000
High
¥4,200
Median
¥3,600
Low
+28% vs Current Price
This information is based on market data from third-party data providers and is for reference only. Investment decisions are your own responsibility.

Earnings Calendar

Updated 2026/08/01
AUG
05
2026
Next Earnings Release
Q3 FY2026
EPS Estimate: ¥52.38
1days

Recent Earnings

Date EPS Est. EPS Actual Surprise
2026/05/14 ¥3.34 ¥-13.82 -513.2%
2026/02/12 ¥71.33 ¥63.97 -10.3%
2025/11/12 ¥47.97 ¥42.00 -12.4%
2025/08/05 ¥49.70 ¥37.27 -25.0%

Shareholder Composition

Updated 2026/08/01
6.7%
Insider Holdings
36.8%
Institutional
56.4%
Public Float
179
Institutional Holders
Insider Holdings 6.7%
Institutional 36.8%
Public Float 56.4%

Top Mutual Funds / ETFs

Updated 2026/08/01

Major Holders

Updated 2026/08/01
Fund Name Ownership Shares Change
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
1.28%
3.6M -0.44%
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
0.84%
2.4M +2.44%
iShares Trust-iShares Core MSCI EAFE ETF
0.63%
1.8M 0.00%
Dimensional ETF Trust-Dimensional International Value ETF
0.36%
1.0M +32.01%
iShares Trust-iShares MSCI EAFE Small-Cap ETF
0.35%
979.5K -0.22%
DFA INVESTMENT TRUST CO-The DFA International Value Series
0.23%
660.6K +9.05%
Institution Ownership Shares Change
Pacer Advisors, Inc.
<0.01%
2.4K -4.59%

Dividend History

Updated 2026/08/02
-%
Dividend Yield
¥53
Annual Dividend
-48.8%
YoY Growth
40.6%
Payout Ratio
Year Dividend Change
2026 ¥53 -48.8%
2025 ¥103 +5.1%
2024 ¥98 +2.6%
2023 ¥95 +8.6%
2022 ¥88 -

Financial Performance

2026/08/02 Updated

Revenue & Profit

Margins

Cash Flow

Financial Health

2022 2023 2024 2025
Income Statement
Revenue ¥1,013,092M ¥1,062,157M ¥1,105,494M ¥1,154,074M
Gross Profit ¥323,249M ¥306,802M ¥327,345M ¥339,100M
Operating Income ¥92,922M ¥75,434M ¥84,322M ¥84,702M
Pretax Income ¥128,955M ¥95,872M ¥87,874M ¥82,864M
Net Income ¥87,497M ¥69,424M ¥50,675M ¥50,800M
EPS ¥303.62 ¥247.39 ¥181.56 ¥186.08
Operating Margin 9.17% 7.10% 7.63% 7.34%
Balance Sheet
Total Assets ¥1,117,459M ¥1,136,217M ¥1,205,288M ¥1,184,472M
Total Equity ¥673,335M ¥711,915M ¥746,529M ¥748,288M
Total Liabilities ¥444,124M ¥424,302M ¥458,759M ¥436,184M
Cash ¥67,409M ¥63,519M ¥106,858M ¥78,191M
Interest-bearing Debt ¥81,266M ¥64,370M ¥49,926M ¥47,799M
Equity Ratio 60.26% 62.66% 61.94% 63.17%
D/E Ratio 0.12 0.09 0.07 0.06
Cash Flow
Operating CF ¥127,526M ¥85,013M ¥107,983M ¥68,979M
Investing CF -¥27,614M -¥36,788M -¥24,604M -¥40,636M
Financing CF -¥76,997M -¥54,734M -¥43,772M -¥61,671M
Free CF ¥34,361M ¥12,843M ¥54,539M ¥12,356M
Efficiency
ROE 12.99% 9.75% 6.79% 6.79%
ROA 7.83% 6.11% 4.20% 4.29%

Latest IR Information

Company Information

English Name Meiji Holdings Co., Ltd.
Japanese Name 明治ホールディングス(株)
Stock Code 2269.T (JPX)
Sector / Industry Consumer Defensive / Packaged Foods
Employees 17,103

About

Meiji Holdings Co., Ltd., together with its subsidiaries, manufactures and sells food products and pharmaceuticals in Japan, China, Asia, North America, Europe, and internationally. It operates in two segments, Food and Pharmaceuticals. The company offers milk, yogurt, cheese, ice cream, chocolate, gummy candy, protein, nutrition for infants and children, beauty supplements, and nutritional products. It also provides drugs for infectious diseases and central nervous system disorders, as well as vaccines, blood plasma products, generic drugs, and animal health products. The company was founded in 1916 and is headquartered in Chuo, Japan.

Data provided by Yahoo Finance